
Sign up to save your podcasts
Or
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
4.3
106106 ratings
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
496 Listeners
37 Listeners
8 Listeners
17 Listeners
19 Listeners
14 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
22 Listeners
87 Listeners
5 Listeners
29 Listeners
15 Listeners
5 Listeners
21 Listeners
3 Listeners
162 Listeners